The neuropeptide substance P (SP) has emerged to be an important proinflammatory mediator in acute pancreatitis (AP). The presence of substance P and its receptor, neurokinin-1 receptor (NK1R) has been shown in the pancreas and the pancreatic acinar cells. In this study, we investigated the unexplored mechanisms that mediate SP and NK1R expression using an in vitro AP model. Pancreatic acinar cells were obtained from pancreas of male Swiss mice. Isolated cells were treated with caerulein to mimic secretagogue pancreatitis. A concentration-dependent study that subjected the cells to 60 min of stimulation by caerulein showed that SP and the transcript from its gene preprotachykinin-A (PPT-A), and NK1R were up-regulated at a supraphysiological concentration of 10 Ϫ7 M. A concentration-dependent study on intracellular kinases, extracellular signal-regulated kinase (ERK1/2), and cJun N-terminal kinase (JNK) and also transcription factors nuclear factor-B (NF-B) and activator protein-1 (AP-1) showed that they were activated when the caerulein concentration was 10 Ϫ7 M. Inhibition of JNK reversed the up-regulation of PPT-A, SP, and NK1R. However, inhibition of ERK1/2 reversed the up-regulation of NK1R but not of PPT-A and SP. Furthermore, we found that specific ERK1/2 and JNK inhibitors reduce NF-B and AP-1 activity. Taken together, our results suggest that supraphysiological concentrations of caerulein up-regulate the expression of SP and NK1R in pancreatic acinar cells, and the signaling molecules that are involved in this up-regulation include ERK1/2, JNK, NF-B, and AP-1.Acute pancreatitis (AP) is the rapid onset of inflammation of the pancreas. The severity of the disease varies widely, because mild forms of acute pancreatitis are self-limiting and the more severe forms could result in multiple organ dysfunction. It is thought that the initiating event of AP is the injury of enzyme-secreting pancreatic acinar cells (Bhatia, 2005). Injured tissue releases cytokines and chemokines, which then leads to a worsening of inflammatory response. The pathophysiology of AP has largely been determined using cellular and animal models of AP. The endogenous hormone cholecystokinin (CCK) or its amphibian ortholog caerulein is often used to induce experimental AP. The concentration of caerulein that mimics physiological concentration is reported to be 10 Ϫ10 M, whereas a supraphysiological concentration of 10 Ϫ7 M is often used to mimic AP in cellular models (Thrower et al., 2008).The binding of substance P (SP) to its receptor, neurokinin-1 receptor (NK1R), was found to be crucial in determining the outcome of AP (Pandol et al., 2007). SP belongs to the tachykinin neuropeptide family and is derived from the product of preprotachykinin-A (PPT-A) gene. SP is mainly produced by neural cells, but other cell types, such as mouse pancreatic acinar cells, are known to express both SP and NK1R (Tamizhselvi et al., 2007). Stimulation of pancreatic acinar cells with SP was found to up-regulate the production